J 2021

Voiding recovery after radical parametrectomy in cervical cancer patients: An international prospective multicentre trial - SENTIX

ZAPARDIEL, I., Roman KOCIAN, C. KOHLER, Jaroslav KLAT, Anna GERMANOVA et. al.

Basic information

Original name

Voiding recovery after radical parametrectomy in cervical cancer patients: An international prospective multicentre trial - SENTIX

Authors

ZAPARDIEL, I. (guarantor), Roman KOCIAN (203 Czech Republic), C. KOHLER, Jaroslav KLAT (203 Czech Republic), Anna GERMANOVA (203 Czech Republic), A. JACOB, Sylva BAJSOVA (203 Czech Republic), G. BOHMER, L. LAY, B. GIL-IBANEZ, Pavel HAVELKA (203 Czech Republic), B. KIPP, G. SZEWCZYK, R. TOTH, J. C. STARINGER, J. DE SANTIAGO, P. J. CORONADO, R. POKA, R. LAKY, M. LUYCKX, M. FASTREZ, Ladislav DUŠEK (203 Czech Republic, belonging to the institution), A. HERNANDEZ and David CIBULA (203 Czech Republic)

Edition

Gynecologic Oncology, SAN DIEGO, ACADEMIC PRESS INC ELSEVIER SCIENCE, 2021, 0090-8258

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30214 Obstetrics and gynaecology

Country of publisher

United States of America

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

Impact factor

Impact factor: 5.304

RIV identification code

RIV/00216224:14110/21:00121473

Organization unit

Faculty of Medicine

UT WoS

000620805400014

Keywords in English

Radical hysterectomy; Parametrectomy; Cervical cancer; Voiding recovery; Nerve-sparing techniques

Tags

Tags

International impact, Reviewed
Změněno: 26/4/2021 14:06, Mgr. Tereza Miškechová

Abstract

V originále

OBJECTIVE: Voiding dysfunctions represent a leading morbidity after radical hysterectomy performed in patients with early-stage cervical cancer. The aim of this study was to perform ad hoc analysis of factors influencing voiding recovery in SENTIX (SENTinel lymph node biopsy in cervIX cancer) trial. METHODS: The SENTIX trial (47 sites, 18 countries) is a prospective study on sentinel lymph node biopsy without pelvic lymphadenectomy in patients with early-stage cervical cancer. Overall, the data of 300 patients were analysed. Voiding recovery was defined as the number of days from surgery to bladder catheter/epicystostomy removal or to post-voiding urine residuum <= 50 mL. RESULTS: The median voiding recovery time was three days (5th-95th percentile: 0-21): 235 (78.3%) patients recovered in <7 days and 293 (97.7%) in 30 days. Only seven (2.3%) patients recovered after 0.001) significantly influenced voiding recovery 7 days post-surgery. Type-B parametrectomy was associated with a higher risk of delayed voiding recovery than type-C1 (OR = 4.69; p = 0.023 vs. OR = 3.62; p = 0.052, respectively), followed by type-C2 (OR = 5.84; p = 0.011). Both previous pregnancy and type C2 parametrectomy indepen-dently prolonged time to voiding recovery by two days. CONCLUSIONS: Time to voiding recovery is significantly related to previous pregnancy and type of parametrectomy but it is not influenced by surgical approach (open vs minimally invasive), age, or BMI. Type B parametrectomy, without direct visualisation of nerves, was associated with longer recovery than nerve-sparing type C1. Importantly, voiding dysfunctions after radical surgery are temporary, and the majority of the patients recover in less than 30 days, including patients after C2 parametrectomy. (C) 2020 Elsevier Inc. All rights reserved.